LALIK

Description

Composition: Lacosamide

Product Type: Oral tablets.

Quantity: 14 tablets per pack.

Strength/Dosage: 50 mg or 100 mg per tablet.
Typically 50 mg to 100 mg twice daily, adjusted based on individual patient needs and as prescribed by a healthcare professional.

Indications:
Management of Epilepsy: Used as monotherapy or adjunctive therapy for the treatment of partial-onset seizures in adults and children.
Seizure Control: Helps reduce the frequency and severity of seizures in individuals with epilepsy.
Adjunctive Therapy: Often prescribed alongside other antiepileptic drugs for better seizure management.
Neurological Stability: Aids in maintaining stable brain activity by modulating neuronal excitation.
Long-Term Epilepsy Management: Suitable for chronic treatment plans to manage epilepsy effectively.